Rodolfo Perez Lopez, MD
Endocrinology · Hialeah, FLNPI 1154359479
Payments from drug & device makers
Across 2,004 payments — averaging $5306.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$6.6M
- Partner Therapeutics, Inc.$2.5M
- Novo Nordisk AS$727K
- AstraZeneca$253K
- Amgen$213K
- Gilead$169K
- plus $207K from 20 others
Across 7 payments — averaging $52,804 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$370K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 66 | $6,572,967 |
| Partner Therapeutics, Inc. | 31 | $2,491,034 |
| Novo Nordisk AS | 1,774 | $727,468 |
| AstraZeneca | 3 | $252,917 |
| Amgen | 1 | $212,556 |
| Gilead | 10 | $169,441 |
| Novartis | 5 | $164,345 |
| Eli Lilly Export S.A. Puerto Rico Branch | 6 | $18,052 |
| Boehringer Ingelheim | 5 | $16,325 |
| GSK | 4 | $5,400 |
| Sanofi-aventis U.S. LLC | 26 | $1,114 |
| Boehringer Ingelheim International GmbH | 6 | $540 |
| Novo Nordisk | 17 | $455 |
| Dexcom, Inc. | 9 | $194 |
| Insulet Corporation | 10 | $184 |
| Xeris Pharmaceuticals, Inc. | 8 | $166 |
| Lilly USA, LLC | 7 | $128 |
| Amneal Pharmaceuticals LLC | 5 | $97 |
| Corcept Therapeutics | 2 | $54 |
| Johnson & Johnson | 2 | $46 |
| AbbVie | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Merck | 1 | $18 |
| Valeritas, Inc. | 1 | $18 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
| Ascensia Diabetes Care US Inc. | 1 | $14 |
How this compares
Too few endocrinology providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology in Hialeah
- Vivian RoseCoral Springs$214K
- Bryan VinikBoca Raton$13K
- Renee FreedmanBoca Raton$10K
- Rolando RodriguezBoca Raton$8K
- Carlos ZapataTallahassee$5K
- Michael FiliMiami$4K
- Mohammad BaigTampa$2K
- Myat MyintHudson$182
- Kathryn JonesBoca Raton$142
- Alan BalsamDeerfield Beach$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.